← Back to Search

Internet-Based Intervention for Fertility Decisions in Cancer Patients

N/A

Waitlist Available

Led By Terri L Woodard

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Newly diagnosed breast tumor, female genital system tumor, colorectal tumor, and/or lymphoma/myeloma

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 2 months

Awards & highlights

Study Summary

This trial studies a decision aid website to help make decisions about fertility in cancer patients. The website provides information about fertility preservation.

Who is the study for?

This trial is for people with certain cancers (like breast, colorectal, lymphoma/myeloma) who might face infertility due to treatment. Participants need internet access and an email address, must understand English, and haven't seen the Pathways decision aid before. Health care providers from a specific Houston location can also join.Check my eligibility

What is being tested?

The study is testing if a website that helps with fertility decisions can assist cancer patients in choosing whether to preserve their ability to have children after treatment. It involves using the website and possibly filling out questionnaires.See study design

What are the potential side effects?

Since this trial involves educational materials rather than medications or medical procedures, there are no direct physical side effects expected from participating.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been recently diagnosed with breast, genital, colorectal cancer, or lymphoma/myeloma.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 2 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 2 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Patients' decisional conflict (Part 1)

Patients' decisional conflict (Part 2)

Secondary outcome measures

Patients' decision-making process (Part 1)

Patients' decision-making process (Part 2)

Other outcome measures

Acceptability of the decision aid website (Part 1)

Feasibility of the multicomponent DS intervention and research methods (Part 2)

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Arm II (standard of care, decision-making website)Experimental Treatment4 Interventions

Participants receive standard of care as in Arm I. Participants also use the decision-making the website.

Group II: Arm I (standard of care)Active Control3 Interventions

Participants receive standard of care including education materials about fertility preservation from the Livestrong organization and a referral for fertility preservation, if requested.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor

2,972 Previous Clinical Trials

1,787,139 Total Patients Enrolled

76 Trials studying Multiple Myeloma

5,657 Patients Enrolled for Multiple Myeloma

National Cancer Institute (NCI)NIH

13,660 Previous Clinical Trials

40,924,112 Total Patients Enrolled

579 Trials studying Multiple Myeloma

188,971 Patients Enrolled for Multiple Myeloma

Terri L WoodardPrincipal InvestigatorM.D. Anderson Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research initiative currently enrolling participants?

"Clinicaltrials.gov data shows that this trial, initially posted on April 23rd 2017 and last updated September 22nd 2022, is not currently searching for participants. Nevertheless, there are 7,548 other medical research projects recruiting patients at the moment."

Answered by AI

Is it feasible for me to join this clinical experiment?

"To be eligible for this research, the participant needs to have lymphoma and must fall in the age range of 18-45. This investigation is actively recruiting a total of 160 subjects."

Answered by AI

Are participants over 35 years of age admissible to this medical trial?

"The requirements for enrolling in this scientific trial stipulate that the patient's age must be between 18 and 45. For those under 18 there are 660 studies available, while 7146 trials exist for people over 65."

Answered by AI

Recent research and studies

pathwaysJournal

<i>pathways</i>: Patient-centred Decision Counselling for Women at Risk of Cancer-related Infertility: A Protocol for a Comparative Effectiveness Cluster Randomised Trial

Woodard, Terri Lynn, Aubri S Hoffman, Laura C Crocker, Deborah A Holman, Derek B Hoffman, Jusheng Ma, Roland L Bassett Jr, Viola B Leal, and Robert J Volk. 2018. “pathways: Patient-centred Decision Counselling for Women at Risk of Cancer-related Infertility: A Protocol for a Comparative Effectiveness Cluster Randomised Trial”. BMJ Open. BMJ. doi:10.1136/bmjopen-2017-019994.

clinicaltrials.govStudy

Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer

2017. "Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03141437.

All > Fertility > Genital Warts